Health Center » In The News » News Briefs 2008

FDA to Halt Sales of Inhalers with CFC’s

The FDA is reminding doctors, pharmacists and asthma patients that inhalers using chloroflurocarbons, or CFC’s, as propellants will no longer be sold in the U.S. after December 31st.  Devices with a different propellant, hydrofluroalkanem, or HFA are replacing the alburterol inhalers.  The change is part of an international agreement to limit usage of CFC, which depletes the earth’s ozone layer.  Alburterol inhalers are among the most widely used machines, with 52 million prescriptions a year.

Infinite Health Resources does not at any point, for any circumstances suggest that you do not follow or stop medical advice of your physician. We do not advocate any drugs that has not been prescribed by your physician, nor suggest that we are medical doctors nor are we giving medical advice. Infinite Health Resources is here purely as a resource.